Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Therapeutic Drug Monitoring|August 1, 1996
Are the major effects of P-glycoprotein modulators due to altered pharmacokinetics of anticancer drugs?M V Relling
Clinical Pharmacy|December 1, 1989
Polymorphic drug metabolismM V Relling
Nature Reviews. Cancer|March 22, 2002
Pharmacogenetics and cancer therapyM V Relling, T Dervieux
Nature Medicine|March 7, 2001
Gazing into a crystal ball-cancer therapy in the post-genomic eraM J Ratain, M V Relling
Clinical Pharmacy|July 1, 1986
Drug-induced hemorrhagic cystitisM V Relling, J E Schunk
Leukemia Research|November 1, 1994
Mercaptopurine vs thioguanine for the treatment of acute lymphoblastic leukemiaW E Evans, M V Relling
British Journal of Haematology|June 10, 2000
Topoisomerase II inhibitor-related acute myeloid leukaemiaC H Pui, M V Relling
Clinical Pharmacology and Therapeutics|March 7, 2007
Should pharmacogenomic studies be required for new drug approval?M V Relling, J M Hoffman
Clinical Pharmacokinetics|June 1, 1989
Clinical pharmacokinetics-pharmacodynamics of anticancer drugsW E Evans, M V Relling
Clinical Pharmacology and Therapeutics|January 29, 2011
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkM V Relling, T E Klein
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Therapeutic Drug Monitoring|August 1, 1996
Are the major effects of P-glycoprotein modulators due to altered pharmacokinetics of anticancer drugs?M V Relling
Clinical Pharmacy|December 1, 1989
Polymorphic drug metabolismM V Relling
Nature Reviews. Cancer|March 22, 2002
Pharmacogenetics and cancer therapyM V Relling, T Dervieux
Nature Medicine|March 7, 2001
Gazing into a crystal ball-cancer therapy in the post-genomic eraM J Ratain, M V Relling
Clinical Pharmacy|July 1, 1986
Drug-induced hemorrhagic cystitisM V Relling, J E Schunk
Leukemia Research|November 1, 1994
Mercaptopurine vs thioguanine for the treatment of acute lymphoblastic leukemiaW E Evans, M V Relling
British Journal of Haematology|June 10, 2000
Topoisomerase II inhibitor-related acute myeloid leukaemiaC H Pui, M V Relling
Clinical Pharmacology and Therapeutics|March 7, 2007
Should pharmacogenomic studies be required for new drug approval?M V Relling, J M Hoffman
Clinical Pharmacokinetics|June 1, 1989
Clinical pharmacokinetics-pharmacodynamics of anticancer drugsW E Evans, M V Relling
Clinical Pharmacology and Therapeutics|January 29, 2011
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkM V Relling, T E Klein
Pageof 18